India faces a potential economic setback following the US decision to impose a 25% tariff on Indian goods from 7 August 2025, and an additional 25% penalty tariff on Russian oil-linked imports from 27 ...

Tariffs and store closures are clouding the brand’s progress, and a lot is riding on the fourth quarter.

India’s Light Vehicle (LV) wholesale figures for June totaled approximately 365k units, representing an 8% month-on-month ...

The expiration of Viatris’s EpiPen patent in September 2025 will likely result in increased competition and lower costs in ...

Gilead's PrEP Yeztugo is set to become the pharma's star asset, with GlobalData forecasting of just under $5bn in 2031.

US pharma major AbbVie recently announced top-line results from one of two parallel studies of the pivotal Phase III UP-AA ...

Quality control and product and recipe development have been some key areas where AI has been used so far in beer production.

Boehringer and Click's CT-155 plus antipsychotics significantly reduced negative symptoms associated with schizophrenia in a Phase III trial ...

Genmab and AbbVie’s Epkinly has met its dual primary endpoints as a second-line combination therapy in relapsed/refractory follicular lymphoma (FL).

The Asia-Pacific (APAC) initial public offering (IPO) market recorded 385 listings raising USD 28.4 billion in the first ...

Insurers which can demonstrate environmental commitments will enhance their brand reputation and improve trust among consumers,' says analyst ...

President Donald Trump is betting that tariffs on imports of vehicles and automotive parts will bring more manufacturing to ...